Spinal Cord Injuries
Conditions
Keywords
Metabolic dysfunction, Nutrition education
Brief summary
The purpose of this research is to assess the effectiveness of a nutrition education program in increasing nutrition knowledge and improving health-related biomarkers in individuals with spinal cord injury (SCI).
Interventions
BEHAVIORALNutrition Education
The intervention will consist of 12 monthly nutrition education sessions catered to people with spinal cord injuries. The curriculum is based on the 2020-2025 Dietary Guidelines for Americans such as consuming recommended amounts of fruits/vegetables, whole grains, etc. The sessions will be approximately 30-60 minutes and will be available in-person.
Sponsors
The Craig H. Neilsen Foundation
University of Miami
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
\- Adults with SCI with complete and incomplete (American Spinal Injury Association Impairment Scale Score A-D) paraplegia or ventilator-independent tetraplegia.
Exclusion criteria
* Participants who do not meet inclusion criteria. * Adults unable to consent. * Individuals who are not yet adults (infants, children, teenagers) * Pregnant women (self-report) * Prisoners
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Nutrition Knowledge | Baseline, 12 months | The General Nutrition Knowledge Questionnaire is an 88-item scale that has a scoring range of 0 to 88 with a high score indicating more knowledge of nutrition. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Cardiometabolic Biomarkers - Potassium | Baseline, 12 months | Measured in millimoles/liter assessed with blood analyses. |
| Change in Cardiometabolic Biomarkers - Chloride | Baseline, 12 months | Measured in millimoles/liter assessed with blood analyses. |
| Change in Cardiometabolic Biomarkers - Blood Urea Nitrogen | Baseline, 12 months | Measured in milligrams/deciliter assessed with blood analyses. |
| Change in Cardiometabolic Biomarkers - Glucose | Baseline, 12 months | Measured in milligrams/deciliter assessed with blood analyses. |
| Change in Cardiometabolic Biomarkers -Triglycerides | Baseline, 12 months | Measured in milligrams/deciliter assessed with blood analyses. |
| Change in Cardiometabolic Biomarkers - Fasting Sodium | Baseline, 12 months | Measured in millimoles/liter assessed with blood analyses. |
| Change in Cardiometabolic Biomarkers - Low Density Lipoprotein Cholesterol | Baseline, 12 months | Measured in milligrams/deciliter assessed with blood analyses. |
| Change in Cardiometabolic Biomarkers - Very-low-density lipoprotein | Baseline, 12 months | Measured in milligrams/deciliter assessed with blood analyses. |
| Change in Cardiometabolic Biomarkers -High-density lipoprotein cholesterol | Baseline, 12 months | Measured in milligrams/deciliter assessed with blood analyses. |
| Change in Cardiometabolic Biomarkers - Hemoglobin a1c | Baseline, 12 months | Measured as a percentage of hemoglobin a1c, assessed with blood analyses. |
| Change in Cardiometabolic Biomarkers - Insulin | Baseline, 12 months | Measured in units of insulin per millimeter (uU/ml) assessed with blood analyses. |
| Change in Cardiometabolic Biomarkers - Total Cholesterol | Baseline, 12 months | Measured in milligrams/deciliter assessed with blood analyses. |
Countries
United States
Outcome results
None listed